Shingrix Shingles Vaccine Recommended for Immunocompromised Adults: CDC Reports
The CDC says it approves of the use of Shingrix in immunocompromised adults, which was contraindicated for the competing shingles live virus vaccine, Zostavax.
Tag Archives: Shingrix
-
-
Shingrix Guillain-Barré Syndrome Risk Seen During 42 Days After Shingles Vaccination: Study
The Shingrix vaccine appears to be linked to a small, but statistically significant, increased risk og Guillain-Barre Syndrome, according to the findings of a study which led to new label…
-
Shingrix Vaccine’s Risk of Guillain-Barré Syndrome Results in New FDA Warning
The Shingrix vaccine, used to prevent shingles, may increase the risk of Guillain-Barre Syndrome, which can cause muscle weakness and paralysis, the FDA warns.
-
Concerns Over Zostavax, Shingrix Side Effects May Be Affecting Shingles Vaccination Rates
Shingles vaccines are not as high as they should be, even as rates of shingles and shingles eye complications are on the rise.
-
Shingrix Vaccine Effective In Stem Cell Transplant Patients, But Injection Site Complications Common: Study
A new study finds Shingrix to be effective in helping prevent stem cell transplant patients from developing shingles, but frequently results in injection site reactions.
-
Vaccination Does Not Decrease Risk Of Shingles-Related Strokes: Study
A new study indicates that giving patients Zostavax and antiviral treatments following a shingles diagnosis does not decrease the risk of herpes zoster-associated strokes.
-
Complications Following Shingles Vaccine Are Serious in About 3% of Cases: CDC
A new CDC report indicates a number of serious events have been linked to the use of Shingrix, but indicates the vaccine is safe overall.
-
Shingrix Shortages Occurring As Doctors Move Away From Zostavax
Doctors rapidly moving away from the Zostavax vaccine may be in part to blame for a shortage of Shingrix, GlaxoSmithKline's competing vaccination, which has been overwhelmed by demand in recent…
-
Shingrix May Prevent Shingles Better Than Zostavax, Despite Increased Injection Site Risks: Study
A new study indicates Shingrix is more effective than Zostavax at preventing shingles, but may carry an increased risk of injection site complications.
-
CDC Warns Of Errors In Giving Shingrix Shingles Vaccines
The CDC warns that some pharmacists may be confused over the differences between Zostavax and the new shingles vaccine, Shingrix, leading to vaccine administration errors.
